Your browser doesn't support javascript.
loading
Occurrence and trends of Clostridioides difficile infections in hospitalized patients: a prospective multicentre cohort study in six German university hospitals, 2016-2020.
Jazmati, Nathalie; Mischnik, Alexander; Kern, Winfried V; Behnke, Michael; Chakraborty, Trinad; Dinkelacker, Ariane; Eisenbeis, Simone; Falgenhauer, Jane; Gastmeier, Petra; Häcker, Georg; Imirzalioglu, Can; Käding, Nadja; Kramme, Evelyn; Peter, Silke; Piepenbrock, Ellen; Rupp, Jan; Schneider, Christian; Schwab, Frank; Seifert, Harald; Tacconelli, Evelina; Trauth, Janina; Biehl, Lena; Walker, Sarah V; Rohde, Anna M.
Affiliation
  • Jazmati N; German Centre for Infection Research (DZIF), Germany; Institute for Medical Microbiology, Immunology and Hygiene, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Labor Dr. Wisplinghoff, Cologne, Germany. Electronic address: n.jazmati@wisplinghoff.de.
  • Mischnik A; German Centre for Infection Research (DZIF), Germany; Department of Infectious Diseases and Microbiology, University Hospital Schleswig-Holstein/Campus Lübeck, Germany; Division of Infectious Diseases, Department of Medicine II, University Medical Centre and Faculty of Medicine, Albert-Ludwigs-Unive
  • Kern WV; Division of Infectious Diseases, Department of Medicine II, University Medical Centre and Faculty of Medicine, Albert-Ludwigs-University, Freiburg, Freiburg, Germany.
  • Behnke M; German Centre for Infection Research (DZIF), Germany; Institute for Hygiene and Environmental Medicine, Charité - University Medicine Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Germany.
  • Chakraborty T; German Centre for Infection Research (DZIF), Germany; Institute of Medical Microbiology, Justus Liebig University Giessen, Germany.
  • Dinkelacker A; German Centre for Infection Research (DZIF), Germany; Institute of Medical Microbiology and Hygiene, University of Tübingen, Tübingen, Germany.
  • Eisenbeis S; German Centre for Infection Research (DZIF), Germany; Division of Infectious Diseases, Department of Internal Medicine 1, University Hospital Tübingen, Tübingen, Germany.
  • Falgenhauer J; German Centre for Infection Research (DZIF), Germany; Institute of Medical Microbiology, Justus Liebig University Giessen, Germany.
  • Gastmeier P; German Centre for Infection Research (DZIF), Germany; Institute for Hygiene and Environmental Medicine, Charité - University Medicine Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Germany.
  • Häcker G; German Centre for Infection Research (DZIF), Germany; Institute for Medical Microbiology and Hygiene, University Medical Centre Freiburg, University of Freiburg, Faculty of Medicine, Freiburg, Germany.
  • Imirzalioglu C; German Centre for Infection Research (DZIF), Germany; Institute of Medical Microbiology, Justus Liebig University Giessen, Germany.
  • Käding N; German Centre for Infection Research (DZIF), Germany; Department of Infectious Diseases and Microbiology, University Hospital Schleswig-Holstein/Campus Lübeck, Germany.
  • Kramme E; German Centre for Infection Research (DZIF), Germany; Department of Infectious Diseases and Microbiology, University Hospital Schleswig-Holstein/Campus Lübeck, Germany.
  • Peter S; German Centre for Infection Research (DZIF), Germany; Institute of Medical Microbiology and Hygiene, University of Tübingen, Tübingen, Germany.
  • Piepenbrock E; German Centre for Infection Research (DZIF), Germany; Institute for Medical Microbiology, Immunology and Hygiene, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Rupp J; German Centre for Infection Research (DZIF), Germany; Department of Infectious Diseases and Microbiology, University Hospital Schleswig-Holstein/Campus Lübeck, Germany.
  • Schneider C; German Centre for Infection Research (DZIF), Germany; Institute for Medical Microbiology and Hygiene, University Medical Centre Freiburg, University of Freiburg, Faculty of Medicine, Freiburg, Germany.
  • Schwab F; German Centre for Infection Research (DZIF), Germany; Institute for Hygiene and Environmental Medicine, Charité - University Medicine Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Germany.
  • Seifert H; German Centre for Infection Research (DZIF), Germany; Institute for Medical Microbiology, Immunology and Hygiene, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses
  • Tacconelli E; German Centre for Infection Research (DZIF), Germany; Division of Infectious Diseases, Department of Internal Medicine 1, University Hospital Tübingen, Tübingen, Germany.
  • Trauth J; German Centre for Infection Research (DZIF), Germany; Department of Internal Medicine (Infectiology), Uniklinikum Giessen, Germany.
  • Biehl L; German Centre for Infection Research (DZIF), Germany; Department I of Internal Medicine, University Hospital of Cologne, Germany.
  • Walker SV; German Centre for Infection Research (DZIF), Germany; Institute for Medical Microbiology, Immunology and Hygiene, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; RKH Regionale Kliniken Holding und Services GmbH, Institute for Clinical Microbiology and Ho
  • Rohde AM; German Centre for Infection Research (DZIF), Germany; Institute for Hygiene and Environmental Medicine, Charité - University Medicine Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Germany.
J Hosp Infect ; 2024 Jul 03.
Article in En | MEDLINE | ID: mdl-38969208
ABSTRACT

BACKGROUND:

For Clostridioides difficile infections (CDI) in Germany no longitudinal multicentre studies with standardized protocols for diagnosing CDI are available. Recent evaluations of general surveillance databases in Germany indicate a downward trend in CDI rates. We aimed to describe the actual burden and trends of CDI in German university hospitals from 2016 to 2020.

METHODS:

Our study is a prospective multicentre study covering six German university hospitals. We report the data in total, stratified by year, by medical specialty as well as by CDI severity. Multivariable regression analyses were performed to assess risk factors for severe CDI.

RESULTS:

We registered 3,780 CDI cases among 1,436,352 patients. The median length of stay (LOS) of CDI cases was 20 days (IQR 11-37) compared with a general LOS of 4.2 days. In-hospital all-cause mortality in CDI patients was 11.7% (n=444/3780), while mortality attributed to CDI was 0.4% (n=16/3761). CDI recurrence rate was comparatively low at 7.2%. The incidence density of severe healthcare-associated healthcare onset (HAHO)-CDI showed a significant decrease from 2.25/10,000 patient days (pd) in 2016 to 1.49/10,000 pd in 2020 (trend calculation p = 0.032).

CONCLUSIONS:

Compared with a European point-prevalence study in 2013/2014, where overall CDI incidence density was 11.2 cases/10,000 pd in Germany (EUCLID), we see in our study halved overall CDI rates of 5.6 cases/10,000 pd in 2020. Our study shows current data on the distribution of CDI cases in German university hospitals and thus provides international comparative data on the key indicators of CDI.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Hosp Infect Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Hosp Infect Year: 2024 Document type: Article
...